BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12483521)

  • 1. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways.
    Kraus AC; Ferber I; Bachmann SO; Specht H; Wimmel A; Gross MW; Schlegel J; Suske G; Schuermann M
    Oncogene; 2002 Dec; 21(57):8683-95. PubMed ID: 12483521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL; Healy ME; Sattler M; Verma S; Lin J; Maulik G; Stiles CD; Griffin JD; Johnson BE; Salgia R
    Oncogene; 2000 Jul; 19(31):3521-8. PubMed ID: 10918610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth.
    Krystal GW; Honsawek S; Litz J; Buchdunger E
    Clin Cancer Res; 2000 Aug; 6(8):3319-26. PubMed ID: 10955819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of akt/protein kinase B signaling by naltrindole in small cell lung cancer cells.
    Chen YL; Law PY; Loh HH
    Cancer Res; 2004 Dec; 64(23):8723-30. PubMed ID: 15574783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of small-cell lung cancer cell growth by simvastatin reveals selective functions of Ras isoforms in growth factor signalling.
    Khanzada UK; Pardo OE; Meier C; Downward J; Seckl MJ; Arcaro A
    Oncogene; 2006 Feb; 25(6):877-87. PubMed ID: 16170339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70s6k-dependent pathway.
    Moore SM; Rintoul RC; Walker TR; Chilvers ER; Haslett C; Sethi T
    Cancer Res; 1998 Nov; 58(22):5239-47. PubMed ID: 9823338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of CD9 enhances adhesion-dependent morphologic differentiation, survival, and matrix metalloproteinase-2 production in small cell lung cancer cells.
    Saito Y; Tachibana I; Takeda Y; Yamane H; He P; Suzuki M; Minami S; Kijima T; Yoshida M; Kumagai T; Osaki T; Kawase I
    Cancer Res; 2006 Oct; 66(19):9557-65. PubMed ID: 17018612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy.
    Warshamana-Greene GS; Litz J; Buchdunger E; García-Echeverría C; Hofmann F; Krystal GW
    Clin Cancer Res; 2005 Feb; 11(4):1563-71. PubMed ID: 15746061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
    Krystal GW; Sulanke G; Litz J
    Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
    Barr LF; Campbell SE; Bochner BS; Dang CV
    Cancer Res; 1998 Dec; 58(23):5537-45. PubMed ID: 9850091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001.
    Marinov M; Ziogas A; Pardo OE; Tan LT; Dhillon T; Mauri FA; Lane HA; Lemoine NR; Zangemeister-Wittke U; Seckl MJ; Arcaro A
    Clin Cancer Res; 2009 Feb; 15(4):1277-87. PubMed ID: 19228731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase-dependent, phosphatidylinositol 3'-kinase, and mitogen-activated protein kinase-independent signaling pathways prevent lung adenocarcinoma cells from anoikis.
    Wei L; Yang Y; Yu Q
    Cancer Res; 2001 Mar; 61(6):2439-44. PubMed ID: 11289112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
    Strassheim D; Shafer SH; Phelps SH; Williams CL
    Cancer Res; 2000 May; 60(10):2730-6. PubMed ID: 10825148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human intestinal epithelial crypt cell survival and death: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways.
    Harnois C; Demers MJ; Bouchard V; Vallée K; Gagné D; Fujita N; Tsuruo T; Vézina A; Beaulieu JF; Côté A; Vachon PH
    J Cell Physiol; 2004 Feb; 198(2):209-22. PubMed ID: 14603523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo.
    Sethi T; Rintoul RC; Moore SM; MacKinnon AC; Salter D; Choo C; Chilvers ER; Dransfield I; Donnelly SC; Strieter R; Haslett C
    Nat Med; 1999 Jun; 5(6):662-8. PubMed ID: 10371505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular models of drug- and radiation-resistant small cell lung cancer.
    Davey RA; Locke VL; Henness S; Harvie RM; Davey MW
    Anticancer Res; 2004; 24(2A):465-71. PubMed ID: 15152945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
    Ali MA; Rosati R; Pettit GR; Kalemkerian GP
    Anticancer Res; 1998; 18(2A):1021-6. PubMed ID: 9615758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix regulation of drug resistance in small-cell lung cancer.
    Hodkinson PS; Mackinnon AC; Sethi T
    Int J Radiat Biol; 2007; 83(11-12):733-41. PubMed ID: 17852559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.